文献速递细胞病理与分子病理

唾液腺FNA「可疑」类别:恶性肿瘤风险及机构间差异

"Suspicious" salivary gland FNA: Risk of malignancy and interinstitutional variability.
PubMed 文献 · Cancer Cytopathol · 2017-10-20

该研究评估5家三级医疗中心唾液腺FNA标本中可疑恶性(SFM)类别的恶性肿瘤风险(ROM)。1997至2014年间共12,606例唾液腺FNA,276例(2.2%)报告为SFM,其中114例(41%)有组织学随访;随访显示95例为恶性肿瘤,ROM为83.3%,5家机构间ROM为74%至88%,差异无统计学意义(p=.78)。

要点

  • 唾液腺FNA的SFM类别ROM为83.3%,提示该类别高度富集恶性肿瘤。
  • 5家机构ROM介于74%至88%,机构间差异无统计学意义(p=.78)。
  • SFM标本中仅41%有组织学随访,解读ROM时需注意随访完整性。

核心结论

  • 唾液腺FNA的SFM标本中83.3%最终为恶性,且机构间ROM无显著差异。
  • SFM类别在唾液腺FNA中高度同质,全球ROM较为相似。

研究设计与样本

  • 研究纳入5家全球三级医疗中心1997至2014年共12,606例唾液腺FNA病例。
  • 其中276例(2.2%)报告为SFM,114例(41%)有组织学随访。

主要发现

  • 114例有组织学随访的SFM病例中95例为恶性肿瘤,ROM为83.3%。
  • 5家参与机构的ROM介于74%至88%。
  • Fisher精确检验(显著性设定p<.05)显示机构间ROM差异无统计学意义(p=.78)。

关键数值与推荐

  • SFM类别用于特定肿瘤在数量或质量上不足以满足恶性标准、 findings不足以作出恶性结论时。
  • SFM标本ROM为83.3%,机构间ROM范围74%至88%,p=.78。

临床怎么用

  • 唾液腺FNA报告为SFM时,应结合83.3%的ROM评估恶性可能性并规划后续管理。
  • 机构间ROM一致性支持SFM类别在全球范围内具有可比性。

局限性

  • 276例SFM中仅114例(41%)有组织学随访,ROM基于随访子集计算。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fine-needle aspiration (FNA) cytology is well accepted as a safe, reliable, minimally invasive, and cost-effective method for the diagnosis of salivary gland lesions. Salivary gland neoplasms are often difficult to diagnose because of morphologic heterogeneity and a variety of epithelial metaplastic changes. Hence, a number of salivary gland FNA specimens yield indeterminate results. For indeterminate FNA specimens, the suspicious-for-malignancy (SFM) category is used when a specific neoplasm falls short in quantity or quality for the criteria for malignancy. Therefore, the findings are not sufficient for a conclusive diagnosis of malignancy. METHODS: This study was designed to evaluate the risk of malignancy (ROM) for the SFM group at 5 tertiary medical centers worldwide with the aforementioned criteria. Among 12,606 salivary gland FNA cases between 1997 and 2014, 276 (2.2%) were reported to be SFN. Specifically, 114 suspicious cases (41%) had histological follow-up. RESULTS: Histological follow-up of the 114 suspicious cases showed 95 malignant tumors indicating a risk of malignancy (ROM) of 83.3%. The ROM varied between 74% and 88% for the 5 participating institutions, and a Fisher's exact test with significance set to p<.05 showed no significant difference in ROM among the institutions (p = .78). CONCLUSIONS: Overall, 83.3% of SFM salivary gland FNA specimens turned out to be malignant; there was no significant interinstitutional variability in the ROMs. The SFM category for salivary gland FNA is very homogeneous, and the ROMs are quite similar worldwide. Cancer Cytopathol 2018;126:94-100. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Maleki Z, Miller JA, Arab SE, et al. "Suspicious" salivary gland FNA: Risk of malignancy and interinstitutional variability. Cancer Cytopathol. 2017. PMID: 29053216. doi:10.1002/cncy.21939

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。